1. Home
  2. APRE vs MMA Comparison

APRE vs MMA Comparison

Compare APRE & MMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • MMA
  • Stock Information
  • Founded
  • APRE 2006
  • MMA 2013
  • Country
  • APRE United States
  • MMA Australia
  • Employees
  • APRE N/A
  • MMA N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • MMA
  • Sector
  • APRE Health Care
  • MMA
  • Exchange
  • APRE Nasdaq
  • MMA Nasdaq
  • Market Cap
  • APRE 21.3M
  • MMA 18.8M
  • IPO Year
  • APRE 2019
  • MMA 2024
  • Fundamental
  • Price
  • APRE $2.92
  • MMA $1.81
  • Analyst Decision
  • APRE Strong Buy
  • MMA
  • Analyst Count
  • APRE 2
  • MMA 0
  • Target Price
  • APRE $15.50
  • MMA N/A
  • AVG Volume (30 Days)
  • APRE 13.3K
  • MMA 82.0K
  • Earning Date
  • APRE 11-07-2024
  • MMA 12-03-2024
  • Dividend Yield
  • APRE N/A
  • MMA N/A
  • EPS Growth
  • APRE N/A
  • MMA N/A
  • EPS
  • APRE N/A
  • MMA N/A
  • Revenue
  • APRE $1,310,839.00
  • MMA $375,175.00
  • Revenue This Year
  • APRE $116.72
  • MMA N/A
  • Revenue Next Year
  • APRE N/A
  • MMA N/A
  • P/E Ratio
  • APRE N/A
  • MMA N/A
  • Revenue Growth
  • APRE 130.31
  • MMA 45.19
  • 52 Week Low
  • APRE $2.15
  • MMA $1.41
  • 52 Week High
  • APRE $8.85
  • MMA $5.25
  • Technical
  • Relative Strength Index (RSI)
  • APRE 34.50
  • MMA N/A
  • Support Level
  • APRE $2.87
  • MMA N/A
  • Resistance Level
  • APRE $3.35
  • MMA N/A
  • Average True Range (ATR)
  • APRE 0.32
  • MMA 0.00
  • MACD
  • APRE -0.12
  • MMA 0.00
  • Stochastic Oscillator
  • APRE 4.50
  • MMA 0.00

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline product is ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About MMA Alta Global Group Limited

Alta Global Group Ltd is a technology company engaged in the provision and administration of mixed martial arts training programs, and gym programs. It provides subscription-based products and services, offering both B2B SaaS solutions and B2C products and programs, covering online engagement, online content, and immersive in-gym experiences. The company's business units are; Trainalta.com; Mixed Martial Arts.com; and Hype.Co, Mobile Marketing solution. Its Alta Platform serves as a comprehensive solution for martial arts and combat sports, offering a blend of four core products: the Warrior Training Program, UFC Fight Fit Program, Alta Academy, and the Alta Community.

Share on Social Networks: